VP
AMGN icon

Verum Partners’s Amgen AMGN Stock Holding History

Verum Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Buy
1,290
+10
+0.8% +$3.42K 0.07% 125
2026
Q1 		$450K Buy
1,280
+22
+2% +$7.84K 0.09% 108
2025
Q4 		$412K Buy
1,258
+12
+1% +$3.81K 0.08% 110
2025
Q3 		$352K Sell
1,246
-14
-1% -$4.06K 0.07% 123
2025
Q2 		$352K Sell
1,260
-16
-1% -$4.53K 0.08% 122
2025
Q1 		$398K Buy
1,276
+7
+0.6% +$2.07K 0.11% 101
2024
Q4 		$331K Sell
1,269
-90
-7% -$26.7K 0.1% 115
2024
Q3 		$438K Buy
1,359
+18
+1% +$5.89K 0.13% 99
2024
Q2 		$419K Buy
1,341
+27
+2% +$7.93K 0.14% 92
2024
Q1 		$374K Buy
1,314
+18
+1% +$5.27K 0.13% 99
2023
Q4 		$373K Sell
1,296
-3
-0.2% -$817 0.15% 93
2023
Q3 		$349K Sell
1,299
-823
-39% -$205K 0.16% 88
2023
Q2 		$471K Buy
+2,122
New +$492K 0.43% 50

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Verum Partners's AMGN Position: Q2 2026 in Review

Verum Partners increased its Amgen (AMGN) stake by 0.78% in Q2 2026, buying an estimated $3.42K and bringing the position to 1,290 shares worth $467K. The position accounts for 0.07% of the portfolio, ranked #125.

Verum Partners first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $471K in Q2 2023. 836 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Verum Partners held 1,290 shares of Amgen worth $467K as of Q2 2026.
  • Verum Partners bought 10 Amgen shares in Q2 2026, an estimated $3.42K.
  • Amgen made up 0.07% of Verum Partners's portfolio in Q2 2026, its #125 holding.
  • Verum Partners first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • Verum Partners's Amgen position peaked at $471K in Q2 2023.
  • 836 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.